It signed over 60 million square feet of leases ... to an 18% annual growth in fee-bearing capital, which reached $539 billion. Moreover, Madison Mid Cap Fund in its Q4 2024 investor letter ...

Shares of NYSE NKE opened at $68.02 on Friday. NIKE has a 52-week low of $65.17 and a 52-week high of $98.04. The firm has a fifty day moving average of $74.70 and a 200-day moving average of $77. ...

BMO Capital Markets’ price objective would indicate a potential upside of 47.19% from the stock’s previous close. A number of other research firms have also recently weighed in on NOA.

On Monday, BMO Capital Markets analyst Phillip Jungwirth upgraded shares of Ovintiv Inc. (NYSE:OVV:CN) (NYSE: OVV), changing the stock rating from Market Perform to Outperform. Alongside this ...

On Monday, BMO Capital Markets analyst Phillip Jungwirth upgraded shares of Ovintiv Inc. (NYSE:OVV:CN) (NYSE: OVV), changing the stock rating from Market Perform to Outperform. Alongside this upgrade, ...

The India units of French advertising and communication companies Publicis Groupe and Havas Network are in separate talks to acquire a majority stake in Sam Balsara-owned Madison World, a media report ...

Commissions do not affect our editors' opinions or evaluations. Capital One combines the convenience of online banking with the reach of a traditional bank. It’s known for its competitive ...

On March 24, 2025, Purpose Unlimited Inc. ("Purpose"), a Canadian financial services firm specializing in asset management and wealth platforms, acquired all the issued and outstanding shares of ...

It operates through Canadian P&C, U.S P&C, BMO Wealth Management, and BMO Capital Markets segments. The company’s personal banking products and services include deposits, mortgages, home lending ...

On March 24, 2025, Boat Rocker Media Inc. (BRMI) entered into definitive agreements with Blue Ant Media Inc. and IDJCo for a reverse takeover and management buyout. Blue Ant, controlled by Michael ...

Alnylam Pharmaceuticals Inc. won expanded US approval for a heart drug that could be the biggest boon yet for the 23-year-old ...